ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced...

Full description

Saved in:
Bibliographic Details
Main Authors LAM, Helen, CULP, Patricia, ROSENTHAL, Arnon, PEJCHAL, Robert, NIELSON, Nels P, LEE, Seung-Joo
Format Patent
LanguageEnglish
Published 26.05.2022
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
Bibliography:Application Number: US202217581471